Detalles de la búsqueda
1.
An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis.
J Hepatol
; 80(4): 576-585, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38101756
2.
Reply: Mycophenolate Mofetil in Autoimmune Hepatitis: Are We Ready for Primetime?
J Hepatol
; 2024 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38885882
3.
Reply to: Comments on "An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis".
J Hepatol
; 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38554845
4.
Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial.
Trials
; 25(1): 61, 2024 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38233878
5.
Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment.
Front Med (Lausanne)
; 10: 1195747, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37564051
6.
Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.
Trials
; 23(1): 1012, 2022 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36514163
7.
Commentary: Commentary: Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment.
Front Med (Lausanne)
; 10: 1297191, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37937138
Resultados
1 -
7
de 7
1
Próxima >
>>